These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3439906)

  • 21. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.
    Tate SK; Depondt C; Sisodiya SM; Cavalleri GL; Schorge S; Soranzo N; Thom M; Sen A; Shorvon SD; Sander JW; Wood NW; Goldstein DB
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5507-12. PubMed ID: 15805193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epoxide of carbamazepine.
    McKauge L; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbamazepine (Tegretol) as an anticonvulsant. A controlled double-blind comparison with diphenylhydantoin (Dilantin).
    Troupin AS; Green JR; Halpern LM
    Acta Neurol Scand Suppl; 1975; 60():13-26. PubMed ID: 1103550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition.
    Simon C; Stieger B; Kullak-Ublick GA; Fried M; Mueller S; Fritschy JM; Wieser HG; Pauli-Magnus C
    Acta Neurol Scand; 2007 Apr; 115(4):232-42. PubMed ID: 17376120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of effect of clonazepam on serum levels of diphenylhydantoin, phenobarbital and carbamazepine.
    Johannessen SI; Strandjord RE; Munthe-Kaas AW
    Acta Neurol Scand; 1977 Jun; 55(6):506-12. PubMed ID: 878840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Repetitive serum determinations of anticonvulsants in epileptic patients].
    Guerreiro CA; Ramos MC; Annes M
    Arq Neuropsiquiatr; 1993 Mar; 51(1):36-40. PubMed ID: 8215928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of single- and multiple-dose carbamazepine on the pharmacokinetics of diphenylhydantoin.
    Lai ML; Lin TS; Huang JD
    Eur J Clin Pharmacol; 1992; 43(2):201-3. PubMed ID: 1425879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic interaction of single doses of quinine and carbamazepine, phenobarbitone and phenytoin in healthy volunteers.
    Amabeoku GJ; Chikuni O; Akino C; Mutetwa S
    East Afr Med J; 1993 Feb; 70(2):90-3. PubMed ID: 8513749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of intravenous phenytoin in children.
    Koren G; Brand N; Halkin H; Dany S; Shahar E; Barzilay Z
    Pediatr Pharmacol (New York); 1984; 4(1):31-8. PubMed ID: 6739185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive functions, epileptic syndromes and antiepileptic drugs.
    Bittencourt PR; Mader MJ; Bigarella MM; Dóro MP; Gorz AM; Marcourakis TM; Ferreira ZS
    Arq Neuropsiquiatr; 1992 Mar; 50(1):24-30. PubMed ID: 1307474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of carbamazepine in reducing polypharmacy in epilepsy.
    Maheshwari MC; Padmini R
    Acta Neurol Scand; 1981 Jul; 64(1):22-8. PubMed ID: 7324872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal of antiepileptic medication in children--effects on cognitive function: The Multicenter Holmfrid Study.
    Aldenkamp AP; Alpherts WC; Blennow G; Elmqvist D; Heijbel J; Nilsson HL; Sandstedt P; Tonnby B; Wåhlander L; Wosse E
    Neurology; 1993 Jan; 43(1):41-50. PubMed ID: 8423909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between doxycycline and some antiepileptic drugs.
    Penttilå O; Neuvonen PJ; Aho K; Lehtovaara R
    Br Med J; 1974 Jun; 2(5917):470-2. PubMed ID: 4600204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
    Leppik IE
    Epilepsy Res Suppl; 1988; 1():85-90. PubMed ID: 3149581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamazepine and phenytoin. Comparison of cognitive effects in epileptic patients during monotherapy and withdrawal.
    Gallassi R; Morreale A; Lorusso S; Procaccianti G; Lugaresi E; Baruzzi A
    Arch Neurol; 1988 Aug; 45(8):892-4. PubMed ID: 3395263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacotherapy of epilepsy--current problems and controversies].
    Schmidt D
    Fortschr Neurol Psychiatr; 1983 Nov; 51(11):363-86. PubMed ID: 6418628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine.
    Osorio I; Reed RC; Peltzer JN
    Epilepsia; 2000 Jul; 41(7):887-94. PubMed ID: 10897162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosage adjustments in response to monitored plasma concentrations: can unblinded staff adhere to objective criteria?
    Sahlroot JT; Pledger GW
    J Biopharm Stat; 1994 Mar; 4(1):91-100. PubMed ID: 8019586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.